This trial aims to evaluate the effectiveness of a Behavioral Modification Working (BMW) Toolkit in improving glycemic control and blood pressure among pregnant women diagnosed with both GDM and PIH.
Pregnant women aged 15-49 years.
Gestational age between 16 and 20 weeks at enrolment.
Diagnosed with both gestational diabetes mellitus (GDM) and pregnancy-induced hypertension (PIH).
At least one prior antenatal visit at the study site.
Pre-existing diabetes mellitus or chronic hypertension prior to pregnancy.
Pre-existing renal disease, thyroid disease, or major hematological disorders.
Multiple pregnancy (e.g., twins, triplets).
Severe psychiatric illness.